Delta 8 body residence

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8  residence, which is one of more than 100 cannabinoids naturally found in cannabis plants, is not present in large amounts within the plant. The high levels of delta-8 THC found in the body are usually due to CBD (hemp-derived cannabis).Customers need to know that delta-8 THC products are not approved or assessed by the FDA as safe for use in any circumstance. They may be promoted in ways that could put people's lives at risk. These products should be kept out of reach of children and pets.

 

There are five things to know about delta-8 THC to make sure you and your loved ones are safe from products that could cause serious health issues.

 

The FDA has not approved or evaluated delta-8 THC products for safe use. They are also being marketed in ways that pose a risk to the general public's health. The FDA has not reviewed them and cleared them to be safe. There are concerns about the labeling and formulation of the products, as well as the different cannabinoid, terpene and delta-8 THC levels.

 

 

Some products may be called "hemp products" which could mislead people who mistakenly associate "hemp” with "nonpsychoactive". FDA is also concerned about the growing number of products that contain delta-8 THC. These products are being advertised for therapeutic or medical purposes even though FDA has not approved them.

 

 

Unsubstantiated claims regarding products that have not been approved by FDA for therapeutic benefits are not only illegal but also a violation of Federal law. People could be at risk if the products are not proven safe and efficient. The misleading marketing of treatments that have not been proven effective poses serious health risks to the public as patients and customers may use them instead of prescribed treatments for serious or fatal diseases.

 

 

 

FDA received adverse reaction reports regarding drugs containing delta-8 THC.FDA received reports about 104 adverse events in patients who took delta-8 THC supplementation between November 1, 2021 and February 28, 2022. Reports:

 

77% of the patients were adults. 8 percent were children under 18 years of age, and 15% did not mention their age. 55% need intervention (e.g. Assessment by emergency medical professionals or hospitalization.66% of respondents experienced adverse reactions after eating delta-8 THC-containing foods (e.g. brownies, brownies Gummies). Brownies, brownies, Gummies. 66% of respondents reported adverse reactions to delta-8 THC-containing food items (e.g. brownies).

 

 

Between January 1st 2021 and February 28th 2022, 2,362 cases involving delta-8 THC were exposed by the National Poison Control Centers. The date that delta-8 THC product codes were entered into this database. It was February 28th 2022. These were the exposure cases reported:

58% of patients were adults. 41% of patients involved were children under 18 years of age, while 1% did not have any age information. 70% of patients needed evaluation at the hospital. 8 percent required admission to a critical care unit. Children accounted for 45 percent of those who needed health facility evaluations.A case of pediatrics was coded for an outcome of a medical cause of death.